Contributes to life and health by whole possible biotechnology technologies
to whole applicable industries
Health Care System
Develop biopharmaceuticals using deer antler-derived cells of Cellogin
The realization of health and welfare for not only humans but also animals and all living things
Foods through the pharmacological effects of deer antler-derived cells and deer antler cell culture fluid
Next-generation convergence technology combining Cellogin’s biotechnology, agriculture and information technology
Business Overview of Cellogin
Cellogin's main products and developing technologies are all successfully commercialized based on the core technology of Cellogin, which are separation, isolation and culture method deer antler-derived cells. Deer antler cell culture fluid of Cellogin has resulted in high-value-added new materials which are cooperated with pharmacological effects of deer antler-derived cells.
In recent years, domestic food, agriculture and livestock industry have been rapidly developed through the development of biotechnology industry, expansion of market size due to income increase, expectation of new biotech products, need to localize the raw material market which depends on imports, and investment by the government. To this end, Cellogin is trying to broaden the application fields of deer antler cell culture fluid.
Deer antler cell culture fluid of Cellogin is both raw material and technology that can contribute sufficiently to cost reduction and high added value by enabling localization in the domestic raw material industry which depends on imports as a novel bio raw material. Deer antler cell culture fluid will lead to the expansion of the domestic market and the development of the export field through continuous research and development.
Main R&D ProjectExclusive ownership of deer antler-derived cells, Separation and isolation technique, Mass culture technique
Main R&D ProjectMeets needs for healthy life, absence of new raw materials other than the deer antler cell culture fluid, verification of pharmaceutical efficacy
Future growth engineTherapeutics based on deer antler-derived cells, Successful entry into the world as a novel raw material